BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Genentech 

1 DNA Way

South San Francisco  California  94080-4990  U.S.A.
Phone: 650-225-1000 Fax: 650-225-6000


SEARCH JOBS

View Clinical Trials from BioPharm Insight

Since 2005, Genentech has been expanding its facilities in Oceanside, about 35 miles north of San Diego. Today, the campus spans 60 acres and includes a multi-product, biotech manufacturing and clinical operations complex with six buildings totaling 500,000 square feet. Upon receiving U.S. Food and Drug Administration licensure in 2007, the Oceanside facility added 90,000 liters of capacity that are now approved for the production of Rituxan and Avastin bulk drug substance.

On the Southern California Coast, halfway between Los Angeles and San Diego, Oceanside is a beautiful beachfront community of roughly 200,000 people. As one of Oceanside’s largest employers, Genentech takes great pride in the impact we have on the community, but also in the impact the community has on our employees.

Please view our company video on YouTube:
http://www.youtube.com/genentech#p/u/1/GJH4X5gxxf0

Connect with us via Social Media:

Facebook: www.facebook.com/GenentechJobs

Twitter: www.twitter.com/GenentechJobs

LinkedIn: www.linkedin.com/company/genentech


 Key Statistics


Email:
Ownership: Subsidiary

Web Site: Genentech
Employees: 10,000+
Symbol: RHHBY
 



Industry
Biotechnology

Segment
Biotherapeutics





 Company News
Genentech (RHHBY), NewLink Genetics Strike $1 Billion+ Cancer Deal 10/20/2014 6:12:16 AM
FDA Grants Priority Review For Genentech (RHHBY)’s Lucentis In Diabetic Retinopathy 10/8/2014 10:55:45 AM
Genentech (RHHBY) Sales Reps Banned At Ascension Health 10/3/2014 6:26:43 AM
Genentech (RHHBY)’s Investigational Combination Of Cobimetinib Plus Zelboraf (Vemurafenib) Provided Significant Benefit To People With Advanced Melanoma Over Zelboraf Alone 9/29/2014 11:56:51 AM
Genentech (RHHBY)'s New Breast Cancer Drug Greatly Extends Survival Rates 9/29/2014 6:22:40 AM
Google Inc.'s Calico To Hire As Many As 150 Staffers; Some May Be Current Genentech (RHHBY) Employees 9/5/2014 7:02:48 AM
Gilead Sciences, Inc. (GILD), "The New Genentech (RHHBY)," Remaps Massive Foster City Campus 8/29/2014 6:44:11 AM
Seragon Pharmaceuticals Announces Closing Of Its Acquisition By Genentech (RHHBY) 8/28/2014 7:36:34 AM
Genentech (RHHBY) Wins Approval To Treat Advanced Cervical Cancer 8/15/2014 7:22:41 AM
Genentech (RHHBY) Submits Supplemental Biologics License Application To FDA For Lucentis Indication In Diabetic Retinopathy 8/8/2014 10:34:47 AM
12345678910...